REGENXBIO Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
REGENXBIO Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q3 2024.
  • REGENXBIO Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 50.8M shares, a 15.6% increase year-over-year.
  • REGENXBIO Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 43.7M shares, a 1.35% increase from 2022.
  • REGENXBIO Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 43.2M shares, a 1.68% increase from 2021.
  • REGENXBIO Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 42.4M shares, a 13.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 50.8M +6.86M +15.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 50.6M +7.07M +16.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 45.7M +2.28M +5.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 43.7M +582K +1.35% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 43.9M +694K +1.61% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 43.5M +420K +0.97% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 43.5M +507K +1.18% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 43.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 43.3M +622K +1.46% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 43.1M +601K +1.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 42.9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q3 2021 42.6M +5.29M +14.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 42.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q3 2020 37.3M +529K +1.44% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q4 2019 36.7M +3.26M +9.76% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 36.8M +2.83M +8.31% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 36.7M +4.59M +14.3% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 36.4M +4.73M +15% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
Q4 2018 33.4M +3.55M +11.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 34M +3.05M +9.85% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 32.1M +1.42M +4.63% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 31.6M +4.96M +18.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 29.9M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 30.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 30.7M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 26.7M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.